D.E. Shaw & Co’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-66,466
Closed -$2.67M 3514
2015
Q4
$2.67M Buy
66,466
+54,846
+472% +$2.52M ﹤0.01% 1902
2015
Q3
$598K Buy
+11,620
New +$771K ﹤0.01% 2943
2015
Q1
Sell
-5,810
Closed -$516K 3722
2014
Q4
$516K Sell
5,810
-5,810
-50% -$526K ﹤0.01% 3300
2014
Q3
$1.14M Sell
11,620
-5,520
-32% -$620K ﹤0.01% 2691
2014
Q2
$2.2M Buy
17,140
+11,330
+195% +$1.41M ﹤0.01% 2231
2014
Q1
$713K Sell
5,810
-12,666
-69% -$1.45M ﹤0.01% 3319
2013
Q4
$2.02M Sell
18,476
-23,647
-56% -$2.37M ﹤0.01% 2525
2013
Q3
$4.1M Buy
42,123
+9,761
+30% +$900K 0.01% 1782
2013
Q2
$2.9M Buy
+32,362
New +$2.67M 0.01% 1782

Other funds holding ENOV

D.E. Shaw & Co's ENOV Position: Q1 2026 in Review

D.E. Shaw & Co increased its Enovis (ENOV) stake by 12% in Q1 2026, buying an estimated $260K and bringing the position to 102,073 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2803.

D.E. Shaw & Co first reported a position in ENOV in Q2 2013 and has held it in 45 quarters since. The position peaked at $27.3M in Q2 2013. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.

  • D.E. Shaw & Co held 102,073 shares of Enovis worth $2.32M as of Q1 2026.
  • D.E. Shaw & Co bought 11,002 Enovis shares in Q1 2026, an estimated $260K.
  • Enovis made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2803 holding.
  • D.E. Shaw & Co first reported a position in Enovis in Q2 2013 and has held it in 45 quarters since.
  • D.E. Shaw & Co's Enovis position peaked at $27.3M in Q2 2013.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.